MFP
TEVA icon

Michael F. Price’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Michael F. Price’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-103,910
Closed -$715K – 126
2019
Q3 		$715K Sell
103,910
-965
-0.9% -$7.39K 0.1% 89
2019
Q2 		$968K Hold
104,875
– – 0.13% 86
2019
Q1 		$1.64M Hold
104,875
– – 0.2% 74
2018
Q4 		$1.62M Hold
104,875
– – 0.22% 74
2018
Q3 		$2.26M Hold
104,875
– – 0.28% 65
2018
Q2 		$2.55M Hold
104,875
– – 0.3% 63
2018
Q1 		$1.79M Hold
104,875
– – 0.21% 75
2017
Q4 		$1.99M Buy
104,875
+50,000
+91% +$752K 0.25% 72
2017
Q3 		$966K Sell
54,875
-665,125
-92% -$15M 0.13% 80
2017
Q2 		$23.9M Hold
720,000
– – 3.1% 8
2017
Q1 		$23.1M Buy
720,000
+23,500
+3% +$802K 2.86% 8
2016
Q4 		$25.2M Buy
696,500
+227,200
+48% +$9.07M 3.06% 7
2016
Q3 		$21.6M Buy
469,300
+29,000
+7% +$1.51M 2.87% 7
2016
Q2 		$22.1M Hold
440,300
– – 2.94% 7
2016
Q1 		$23.6M Hold
440,300
– – 3.31% 6
2015
Q4 		$28.9M Hold
440,300
– – 3.56% 6
2015
Q3 		$24.9M Hold
440,300
– – 3.72% 5
2015
Q2 		$26M Hold
440,300
– – 3.42% 7
2015
Q1 		$27.4M Sell
440,300
-7,200
-2% -$419K 3.63% 7
2014
Q4 		$25.7M Sell
447,500
-52,500
-11% -$2.92M 3.14% 9
2014
Q3 		$26.9M Hold
500,000
– – 3.35% 7
2014
Q2 		$26.2M Buy
500,000
+111,600
+29% +$5.7M 3.21% 6
2014
Q1 		$20.5M Sell
388,400
-11,600
-3% -$536K 2.5% 12
2013
Q4 		$16M Buy
400,000
+50,000
+14% +$1.97M 2.07% 22
2013
Q3 		$13.2M Hold
350,000
– – 1.76% 22
2013
Q2 		$13.7M Buy
+350,000
New +$13.6M 1.84% 21

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Michael F. Price's TEVA Position: Q4 2019 in Review

Michael F. Price sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2019, closing a stake of 103,910 shares — an estimated $715K sold.

Michael F. Price first reported a position in TEVA in Q2 2013 and held it in 26 quarters. The position peaked at $28.9M in Q4 2015. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

  • Michael F. Price reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2019 after selling out during the quarter.
  • Michael F. Price sold 103,910 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $715K.
  • Michael F. Price first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 26 quarters.
  • Michael F. Price's Teva Pharmaceutical Industries Limited position peaked at $28.9M in Q4 2015.
  • 437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on Michael F. Price's 13F filing for Q4 2019, filed 14 Feb 2020.